By Douglas Johnson, MD, MSCI, Assistant Professor of Medicine & Clinical Director, Melanoma, Vanderbilt-Ingram Cancer Center  |  May 31, 2017

Profiling Melanoma to Predict Immune Therapy Success

May is Melanoma awareness month, and our series on melanoma continues with a discussion with Dr. Douglas B. Johnson of the Vanderbilt-Ingram Cancer Center. Dr. Johnson leads Vanderbilt’s melanoma clinical and research program, overseeing clinical trials, patient care and translational research. His research interests focus on developing new immune and…more.

By Jennifer King, PhD, Director of Science and Research, Lung Cancer Alliance  |  Oct 5, 2016

Lung Cancer Alliance Moves Research Forward Through Innovative Partnerships

This week, Real World Health Care speaks with Jennifer King, Ph.D., Director of Science and Research for the Lung Cancer Alliance. The Lung Cancer Alliance is the leading and highest rated nonprofit organization dedicated to fighting lung cancer in the nation. Since 1995, it has played a critical role in…more.

Close menu